These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12426861)

  • 1. [Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].
    Dreikorn K; Berges R; Pientka L; Jonas U
    Urologe A; 2002 Sep; 41(5):447-51. PubMed ID: 12426861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
    Dreikorn K
    World J Urol; 2002 Apr; 19(6):426-35. PubMed ID: 12022711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
    Ooi SL; Pak SC
    J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
    Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
    Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():103-8. PubMed ID: 16261945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
    Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
    Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
    Squadrito F; Morgia G
    Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
    Levin RM; Das AK
    Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pygeum africanum (Prunus africanus) (African plum tree). Monograph.
    Altern Med Rev; 2002 Feb; 7(1):71-4. PubMed ID: 11896748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.